- Home
- GSK vs MDLZ Comparison
GSK vs MDLZ Comparison
Compare GSK & MDLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- MDLZ
- Stock Information
- Founded
- GSK 1715
- MDLZ 2000
- Country
- GSK United Kingdom
- MDLZ United States
- Employees
- GSK N/A
- MDLZ N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- MDLZ Packaged Foods
- Sector
- GSK Health Care
- MDLZ Consumer Staples
- Exchange
- GSK Nasdaq
- MDLZ Nasdaq
- Market Cap
- GSK 74.6B
- MDLZ 77.6B
- IPO Year
- GSK N/A
- MDLZ N/A
- Fundamental
- Price
- GSK $36.64
- MDLZ $64.67
- Analyst Decision
- GSK Hold
- MDLZ Buy
- Analyst Count
- GSK 4
- MDLZ 17
- Target Price
- GSK $47.00
- MDLZ $70.06
- AVG Volume (30 Days)
- GSK 5.2M
- MDLZ 11.2M
- Earning Date
- GSK 02-05-2025
- MDLZ 02-04-2025
- Dividend Yield
- GSK 4.21%
- MDLZ 2.91%
- EPS Growth
- GSK N/A
- MDLZ N/A
- EPS
- GSK 0.78
- MDLZ 3.42
- Revenue
- GSK $39,280,393,592.00
- MDLZ $36,441,000,000.00
- Revenue This Year
- GSK $6.43
- MDLZ $5.32
- Revenue Next Year
- GSK $5.34
- MDLZ $4.28
- P/E Ratio
- GSK $23.15
- MDLZ $18.91
- Revenue Growth
- GSK 3.46
- MDLZ 1.18
- 52 Week Low
- GSK $31.72
- MDLZ $53.95
- 52 Week High
- GSK $45.93
- MDLZ $76.06
- Technical
- Relative Strength Index (RSI)
- GSK 58.60
- MDLZ 73.99
- Support Level
- GSK $36.35
- MDLZ $59.82
- Resistance Level
- GSK $37.22
- MDLZ $62.19
- Average True Range (ATR)
- GSK 0.62
- MDLZ 1.56
- MACD
- GSK 0.04
- MDLZ 0.69
- Stochastic Oscillator
- GSK 65.58
- MDLZ 98.35
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About MDLZ Mondelez International Inc.
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (49% of sales), chocolate (30%), gum/candy (12%), beverage (3%), and cheese and grocery (6%) aisles, as of the end of fiscal 2023. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury, among others. The firm derives around one third of revenue from developing markets, just more than one third from Europe, and the remainder from North America.